Multiple Testing in the Context of Group Sequential Designs presented by Dr. Yevgen Tymofyeyev and Dr. Michael Grayling, Johnson & Johnson
2:00 PM
SMART-MC: Characterizing the Dynamics of Multiple Sclerosis Therapy Transitions Using a Covariate-Based Markov Model presented by Dr. Priyam Das, Virginia Commonwealth University
2:45 PM
Harnessing Simulation to Inform Endpoint Selection in Cardiovascular Trials presented Dr. Stephan Ogenstad, Statogen Consulting – Co-Authored by Greg Ginn, ReAltaSciences
4:00 PM
Poster Session
9:00 AM
Keynote Address: RCTS, Real-World Data and the Patent Wars: Lies, Damn Lies, and Biostatistics Case Study presented by Dr. Stephen Ogenstad, Statogen Consulting
10:00 AM
Break
10:15 AM
Leveraging Baseline Covariate Adjustment Methods in Oncology Time-to-Event Studies presented by Dr. Daniel Backenroth, Johnson & Johnson
11:00 AM
Driving Operational Excellence: The Power of Statistical Innovation in Clinical Development presented by Dr. Fei Chen, Johnson & Johnson
11:45 AM
Lunch Break
12:45 PM
Bile Acids Are the Strong Indicators for the Progression of Metabolic Dysfunction Associated Steatotic Liver Disease in Ethnically Diverse Populations presented by Dr. Ekaterina Smirnova, Virginia Commonwealth University